The Mission Report


Marcum MicroCap Conference
Thursday, May 29th, 2014 - Grand Hyatt Hotel, New York, NY

Presenting Companies: A-M N-Z

 

5Barz International, Inc. (BARZ)

5Barz International, Inc. (OTCQB: BARZ) is focused on the global commercialization of a patented product technology branded under the name 5BARz™. The technology is a cellular network infrastructure device designed for use in the small office, home or for when users are mobile. 5BARz™ utilizes a patented technology to create a highly engineered, single-piece, plug 'n play unit that strengthens weak cellular signals to deliver high quality signals for voice, data and video reception on cell phones and other cellular-equipped devices. For more information, visit the company’s website at www.5barz.com

Acme United Corp. (ACU)

Acme United Corp. (NYSE: ACU) is a supplier of innovative cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company’s family of brands includes Westcott®, Clauss®, Camillus®, PhysiciansCare® and Pac Kit®. Acme has developed and patented a carbo-nitride coating that enhances the performance of its Titanium Bonded scissors and other products, which are manufactured through the company’s facilities in the United States, Canada, Germany, Hong Kong and China. For more information, visit the company’s website at www.acmeunited.com

Aemetis, Inc. (AMTXD)

Aemetis, Inc. (OTCQB: AMTXD), an advanced fuels and renewable chemicals company, owns and operates an ethanol and animal feed plant in California, the first upgraded facility approved by the EPA to produce D5 Advanced Biofuels using the milo/biogas/CHP pathway. Aemetis also built, owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India, and operates an R&D laboratory at the Maryland Biotech Center. Additionally, Aemtis holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For more information, visit the company’s website at www.aemetis.com

Amarantus BioScience Holdings, Inc. (AMBS)

Amarantus BioScience Holdings, Inc. (OTCBB: AMBS) is a biotech company discovering and developing first-in-class treatments for diseases associated with the dysfunction of a wide range of biological pathways, including protein misfolding, cell cycle dysregulation, neurodegeneration and apoptosis (Programmed Cell Death). The company is focused on developing certain small molecules, biologics and biomarkers surrounding the intellectual property and proprietary technologies it owns and to which it has licenses to treat and/or diagnose Parkinson’s disease, Alzheimer’s disease, Retinitis Pigmentosa and other human diseases. For more information, visit the company’s website at www.amarantus.com

American Sands Energy Corp. (AMSE)

American Sands Energy Corp. (OTCBB: AMSE) is using its proprietary technology for the extraction of oil and other naturally occurring hydrocarbons contained in oil sands, shale, and similar types of geologic structures prevalent in the Mountain West region of North America. The Company’s process has proven successful in laboratory tests on oil sands from the Green River Formation in Utah; validity of this technology has been demonstrated through the operation of a prototype extraction unit. The company has under lease oil sand deposits in Utah containing approximately 200 million barrels of recoverable bitumen. For more information, visit the company’s website at www.americansands.com

AntriaBio, Inc. (ANTB)

AntriaBio, Inc. (OTCQB: ANTB) is a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic disease. AB101, AntriaBio's lead product candidate, is an injectable once-a-week basal insulin for Type 1 and Type 2 diabetes. AntriaBio’s development strategy combines FDA-approved pharmaceutical agents with the company’s proprietary delivery technology. One of the company’s central patents and patent applications is for the conjugation of bioactive agents, including insulin; this underlying technology is approved in Europe and Australia and is patent pending in the U.S., Canada, Japan, China, Hong Kong, Brazil and India. For more information, visit the company’s website at www.antriabio.com

Apollo Medical Holdings, Inc. (AMEH)

Apollo Medical Holdings, Inc. (OTCBB: AMEH) is an integrated, physician-centric healthcare delivery company focused on providing high-quality multi-disciplinary care. To achieve this goal, the company leverages its integrated healthcare delivery platform comprised of four affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association) and ApolloMed Care Clinics. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, visit the company’s website at www.apollomed.net

Applied DNA Sciences (APDN)

Applied DNA Sciences (OTCQB: APDN) provides botanical-DNA based security and authentication solutions and services that can help companies, governments and consumers protect their products, brands, supply chains and intellectual property from theft, counterfeiting, fraud and diversion. The company’s SigNature® DNA is an uncopyable marker that is at the core of a family of products such as SigNature T® for textiles, the DNAnet® antitheft product, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators. For more information, visit the company’s website at www.adnas.com

Arch Therapeutics (ARTH)

Arch Therapeutics (OTCBB: ARTH) is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking during surgery and trauma care. The company’s products are based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, AC5™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures. For more information, visit the company’s website at www.archtherapeutics.com

Atlasta Resources Corp. (ATL)

Atlasta Resources Corp. (NYSE: ATL) is a black economic empowerment (BEE) platinum group metals (PGM) mining, exploration and development company, with assets located on the Bushveld Igneous Complex of South Africa. Atlatsa holds a controlling interest in Bokoni Platinum Mines (formerly Lebowa Platinum Mines) from Anglo Platinum, which currently products approximately 150 000 4E ounces on an annualised basis. The Bokoni acquisition also gives Atlatsa controlling interests in the Ga-Phasha Project, located adjacent to Bokoni, and the Boikgantsho and Kwanda Projects. For more information, visit the company’s website at www.anooraqresources.com

Atossa Genetics (ATOS)

Atossa Genetics (NASDAQ: ATOS) is a molecular diagnostics company developing innovative breast health products and services designed to improve breast health. The company's laboratory developed tests (LDTs) are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The LDTs and the company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, visit the company’s website at www.atossagenetics.com

Auxilio, Inc. (AUXO)

Auxilio, Inc. (OTCQB: AUXO) is a management services company for the healthcare industry. The company’s focus is to provide turnkey managed print services to healthcare clients via situational analysis, strategy development and implementation to ultimately reduce cost and increase employee productivity. Auxilio serves a national portfolio of more than 100 health care facilities and manages approximately 1.6 billion documents annually from devices supporting more than 250,000 caregivers. For more information, visit the company’s website at www.auxilioinc.com

BioLargo, Inc. (BLGO)

BioLargo, Inc. (OTCQB: BLGO) manufactures technology-based products that help solve global issues that threaten water, food, agriculture, healthcare and energy. The company’s Advanced Oxidation Systems includes its AOS Filter, designed to eliminate toxic contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System and operates three subsidiaries: BioLargo Water; Odor-No-More, serving the pet, equine, and consumer markets; and Clyra Medical Technologies, focused on advanced wound care management and preparing to make FDA 510(k) applications in 2014. For more information, visit the company’s website at www.biolargo.com

Biorestorative Therapies, Inc. (BRTX)

Biorestorative Therapies, Inc. (OTCBB: BRTX) develops products and medical procedures using cell and tissue protocols, primarily involving adult stem cells. The company’s portfolio includes brtxDISC™, an investigational non-surgical treatment for protruding, bulging and herniated lumbar discs; ThermoStem®, under development for metabolic disorders including diabetes and obesity; and brtx-C Cosmetic, which has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin. The company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand. For more information, visit the company’s website at www.biorestorative.com

BioSyent (BIOYF)

BioSyent (OTCPK: BIOYF) is a profitable, growth-oriented specialty pharmaceutical company seeking to in-license or acquire innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. Once a product of interest has been found, BioSyent then acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Upon approval, BioSyent markets the product throughout Canada. For more information, visit the company’s website at www.biosyent.com

Bitcoin Shop, Inc. (BTCS)

Bitcoin Shop, Inc. (OTCQB: BTCS) operates an ecommerce website where consumers can purchase products using virtual currency such as bitcoin, litecoin and dogecoin, which use peer-to-peer networks to facilitate instant payments. Bitcoin, litecoin and dogecoin issuances and transactions are carried out collectively by the network, with no central authority, and allow users to make verified transfers. The company’s ecommerce website features a searchable selection of more than 400 categories and more than 140,000 items. For more information, visit the company’s website at www.bitcoinshop.us

Black Ridge Oil & Gas (ANFC)

Black Ridge Oil & Gas (OTCQB: ANFC) is a non-operating exploration and production company in the Bakken and Three Forks play. Black Ridge has participated in drilling more than 230 Bakken or Three Forks wells in North Dakota and Montana since 2010. The company currently controls more than 10,000 net Bakken and/or Three Forks acres, leveraging experienced management, disciplined operation, low overhead and an aggressive acreage acquisition strategy. For more information, visit the company’s website at www.blackridgeoil.com

Blue Calypso (BCYP)

Blue Calypso (OTCBB: BCYP) develops digital innovation products and services for the social media marketplace using its patented IP portfolio. The company enables businesses to use digital advertising to share and socialize brand content as well as track performance, monitor engagements and gather analytics. Blue Calypso’s client base includes large, well-known consumer facing companies in automotive, retail, travel and consumer goods. Blue Calypso licenses its IP in addition to offering digital innovation services through Blue Calypso Labs and solutions including POPSHARE™, SOCIALECHO™, EMGAGE™ and DashTAGG™. For more information, visit the company’s website at www.bluecalypso.com

Boston Therapeutics, Inc. (BTHE)

Boston Therapeutics, Inc. (OTCQB: BTHE) addresses unmet medical needs in diabetes and inflammatory diseases through the development, manufacturing and commercialization of novel compounds based on complex carbohydrate chemistry. The company's initial product is comprised of: BTI320, a chewable drug candidate for prevention of diabetes and its complications; IPOXYN™, an anti-necrosis therapeutic agent targeting human and animal tissues and organ systems deprived of oxygen and in need of metabolic support; and OXYFEX™, the only oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. For more information, visit the company’s website at www.bostonti.com

Caliber Imaging & Diagnostics, Inc. (LCDX)

Caliber Imaging & Diagnostics, Inc. (OTCBB: LCDX) is a medical technologies company that designs, develops and markets innovative imaging solutions that shows tissue at the cellular level. The company’s imaging technology platform, Vivascope®, enables researchers and clinicians the ability to view and analyze without a biopsy. U.S. FDA 510(k) cleared, VivaScope has regulatory approval in most major markets. VivaScope also has significant applications in testing and analysis in the cosmetics industry. For more information, visit the company’s website at www.caliberid.com

Calpian, Inc. (CLPI)

Calpian, Inc. (OTCQB: CLPI) operates through its subsidiaries to provide an integrated suite of payment processing services and related software enabling products to the U.S. merchant community. The company offers credit and debit card processing, ACH, mobile acceptance, and gateway payment solutions to U.S. merchants operating in a physical business environment and/or over the Internet, and in settings requiring both wired and wireless payment solutions. Calpian subsidiary Money-on-Mobile, a pre-paid mobile payment solutions platform, serves approximately 175,000 retail locations in India and has been utilized by over 82 million unique customers. For more information, visit the company’s website at www.calpian.com

Cardinal Energy Group, Inc. (CEGX)

Cardinal Energy Group, Inc. (OTCBB: CEGX) is an oil and natural gas producer within the United States. The company focuses on known formations that have significant proven reserves remaining that can be produced economically. Cardinal targets fields with wells that may need remediation due to neglect or undercapitalization, and exploits these undervalued assets by acquiring a majority working interest in the prospect and then applies the company’s calculated development plan. Cardinal also seeks acquisitions of over-leveraged companies when there is a clear upside from their purchase based on strong commodity prices. For more information, visit the company’s website at www.cardinalenergygroup.com

CAS Medical Systems, Inc. (CASM)

CAS Medical Systems, Inc. (NSADAQ: CASM) designs and manufactures non-invasive vital signs monitoring technologies and products designed to deliver accurate, reliable patient data resource for doctors and clinicians worldwide. CASMED provides its products to hospitals, emergency medical services, home care providers, and original equipment manufacturers (OEMs). These products include: FORE-SIGHT® Absolute Tissue Oximeter; blood pressure measurement technology; vital signs monitors; and supplies for neonatal intensive care. For more information, visit the company’s website at www.casmed.com

CEL-SCI Corp. (CVM)

CEL-SCI Corp. (NYSE: CVM) is focused on research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system. Its lead investigational therapy, Multikine injection, is currently being studied in a pivotal global Phase 3 clinical trial as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine for Rheumatoid. LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1) and the Spanish Flu. For more information, visit the company’s website at www.cel-sci.com

Celator Pharmaceuticals, Inc. (CPXX)

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is focused on developing new and more effective therapies to treat cancer. CombiPlex®, the company's proprietary drug ratio technology platform, represents a novel approach that identifies molar ratios of drugs that will deliver a synergistic benefit, and locks the desired ratio in a nano-scale drug delivery vehicle that maintains the desired ratio in patients to improve clinical outcomes. Celator’s pipeline includes two clinical stage products: CPX-351 for the treatment of acute myeloid leukemia, and CPX-1 for the treatment of colorectal cancer; as well as several preclinical stage product candidates. For more information, visit the company's website at www.celatorpharma.com

Cemtrex, Inc. (CTEI)

Cemtrex, Inc. (OTCBB: CTEI) is a diversified technology company that provides solutions to meet various industrial challenges. Via wholly owned subsidiary, ROB Cemtrex GmbH, the company provides electronic manufacturing services to diverse industries including medical, industrial, automation and renewable energies. Cemtrex sells a line of air filtration and environmental control products through its subsidiary Griffin Filters, LLC, and through its Monitoring Instruments and Products (MIP) division, manufactures, sells, and services instruments, software and systems for monitoring emissions of greenhouse gases, hazardous gases, particulate and other regulated pollutants. For more information, visit the company’s website at www.cemtrex.com

Cesca Therapeutics, Inc. (KOOL)

Cesca Therapeutics, Inc. (NASDAQ: KOOL) is engaged in the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company’s automated blood and bone marrow processing systems enable the separation, processing and preservation of cell and tissue therapy products. Its current portfolio includes the SurgWerks™ Platform, AXP(R) AutoXpress(R) Platform (AXP), the MarrowXpress Platform (MXP), the Res-Q™ 60 (Res-Q) point-of-care system, and the BioArchive(R) System. For more information, visit the company’s website at www.cescatherapeutics.com

Champions Oncology, Inc. (CSBR)

Champions Oncology, Inc. (OTCQB: CSBR) develops advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice to create TumorGrafts that preserve the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. For more information, visit the company’s website at www.championsoncology.com

Cinedigm Corp. (CIDM)

Cinedigm Corp. (NASDAQ: CIDM) is an independent content distributor with direct relationships with more than 60,000 physical retail stores and digital platforms, including Wal-Mart, Target, iTunes, Netflix and Amazon. Cinedigm has a library of nearly 50,000 titles and episodes of award-winning documentaries from Docurama Films®, next-gen Indies from Flatiron Film Company®, acclaimed independent films and festival picks through partnerships with the Sundance Institute and Tribeca Films, and a wide range of content from brand name suppliers. The company is also active in the direct-to-consumer digital network space and has announced a Comic Con channel for launch in early fall. For more information, visit the company’s website at www.cinedigm.com

ClearSign Combustion Corp. (CLIR)

ClearSign Combustion Corp. (NASDAQ: CLIR) develops technologies designed to improve key performance characteristics of combustion systems, including energy efficiency, emissions control, fuel flexibility and overall cost effectiveness. The company’s Duplex™ Burner Architecture and Electrodynamic Combustion Control™ (ECC™) platform technologies improve control of flame shape and heat transfer and optimize the complex chemical reactions that occur during combustion in order to minimize harmful emissions. For more information, visit the company’s website at www.clearsign.com

CounterPath Corp. (CPAH)

CounterPath Corp. (NASDAQ: CPAH) is an award-winning provider of SIP-based desktop and mobile VoIP software products and solutions. CounterPath’s Bria softphones for desktop and mobile devices, paired with the company’s server applications and Fixed Mobile Convergence (FMC) solutions, enable service providers, OEMs and enterprises large and small around the globe to offer a seamless and unified communications experience across both fixed and mobile networks. The company’s solutions power the voice and video calling, messaging, and presence offerings of customers such as Alcatel-Lucent, AT&T, Avaya, BroadSoft, BT, Cisco Systems, GENBAND, Metaswitch Networks, Mitel, NEC, Network Norway, Rogers and Verizon. For more information, visit the company’s website at www.counterpath.com

Critical Outcome Technologies, Inc. (COT)

Critical Outcome Technologies, Inc. (NYSE: COT) is a leading‐edge technology company focused on accelerating the discovery and development of small molecules to significantly reduce the time and cost to bring new drugs to market. The company’s proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed through chemical optimization and preclinical testing. For more information, visit the company’s website at www.criticaloutcome.com

Cryoport, Inc. (CYRX)

Cryoport, Inc. (OTCBB: CYRX) provides comprehensive cryogenic logistics solutions to the life sciences industry, leveraging a combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. The company’s capabilities range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics. Its packaging, built around its Cryoport Express® liquid nitrogen dry vapor shippers, is validated to maintain a constant -150°C temperature for 10 or more days of dynamic shipment duration. For more information, visit the company’s website at www.cryoport.com

Customers Bancorp, Inc. (CUBI)

Customers Bancorp, Inc. (NASDAQ: CUBI), the parent holding company of Customers Bank headquartered in Phoenixville, Pennsylvania, is an equal housing lender that provides a full range of banking services to small and medium-sized businesses, professionals, individuals and families through offices in Pennsylvania, New York, Rhode Island, Massachusetts and New Jersey. Customers Bank employs a High Tech/High Touch strategy that uses industry-leading technology to provide customers better access to their money, as well as a continually expanding portfolio of loans to small businesses, multi-family projects, mortgage companies and consumers. For more information, visit the company’s website at www.customersbank.com

DecisionPoint Systems, Inc. (DPSI)

DecisionPoint Systems, Inc. (NASDAQ: DPSI) is an enterprise systems integrator that provides improved productivity and operational advantages to its clients by helping them move their business decision points closer to their customers. Using mobile computing technologies, DecisionPoint designs, develops, deploys and maintains enterprise class mobile computing solutions that connect a client’s mobile workforce to one another as well as to the enterprise system(s). DecisionPoint utilizes all the latest wireless, mobility and RFID technologies. For more information, visit the company’s website at www.decisionpt.com

DelMar Pharmaceuticals, Inc. (DMPI)

DelMar Pharmaceuticals, Inc. (OTCBB: DMPI) is focused on the development and commercialization of proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 is backed by extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. For more information, visit the company’s website at www.delmarpharma.com

Direct Insite Corp. (DIRI)

Direct Insite Corp. (OTCBB: DIRI) provides cloud-based e-invoicing solutions for accounts payable, accounts receivable and payments automation. The company’s services are currently used by more than 450,000 suppliers and customers in more than 100. Direct Insite’s Invoices On-Line™ platform provides critical procurement, shared services and treasury functionality, which includes: company profile management, e-invoicing, workflow management, payment processing, spend management and business intelligence, dynamic discounting and supply chain financing. For more information, visit the company’s website at www.directinsite.com

Document Security Systems, Inc. (DSS)

Document Security Systems, Inc. (NYSE: DSS) has developed a suite of products and solutions that are used by governments, corporations and financial institutions to defeat fraud and to protect brands and digital information from the global risk of counterfeiting. DSS technologies help ensure the authenticity of both digital and physical financial instruments, identification documents, sensitive publications, brand packaging and websites. The company continually invests in research and development to meet the ever-changing security needs of its clients and offers licensing of its patented technologies through its subsidiary, DSS Technology Management, Inc. For more information, visit the company’s website at www.DSSsecure.com

DS Healthcare Group (DSKX)

DS Healthcare Group (NASDAQ: DSKX) is a developer of biotechnology for topical therapies and built a portfolio of personal care products and additional innovations in pharmaceutical projects. The company sells through a network of major domestic salons and spas, specialty retail channels and through distributors worldwide including Japan, Mexico, Brazil, Australia, Canada, China, throughout Europe and Asia. DS Healthcare’s strategy is to capitalize on opportunities to increase revenue, market share, and profitability in partnership with a worldwide distribution network. For more information, visit the company’s website at www.dslaboratories.com

Ellomay Capital Ltd. (ELLO)

Ellomay Capital Ltd. (NYSE: ELLO) is an Israeli-based company operating in the global energy and infrastructure sectors. To date, Ellomay has invested significant funds in the renewable and clean energy power plants in Israel, Italy and Spain, including approximately 22.6 MW of photovoltaic power plants in Italy, 85% of 2.3 MW of photovoltaic power plant in Spain, and in 7.5% indirect interest, with an option to increase its holdings to approximately 9.375%, in Dorad Energy Ltd., Israel's largest private power plant, which will produce approximately 800 MW. For more information, visit the company’s website at www.ellomay.com

Energous Corp. (WATT)

Energous Corp. (NASDAQ: WATT) is developing WattUp™, a wireless charging technology designed to transform electronic devices are charged. WattUp is a novel, patent-pending solution that delivers intelligent, scalable power via the same radio bands as a Wi-Fi router. The product differs from current wire-free charging systems in that it allows users to roam and use their devices while charging, eliminating the need to plug in the devices or place them on a charging mat. Energous will initially license WattUp to the mobile accessory market. For more information, visit the company’s website at www.energous.com

Electro Scientific Industries, Inc. (ESIO)

Electro Scientific Industries, Inc. (NASDAQ: ESIO) provides innovative, laser-based manufacturing solutions for the microtechnology industry, partnering with its customers to make breakthrough technologies possible in the microelectronics, semiconductor and other emerging industries. The company’s systems enable precise structuring and testing of micron to submicron features in smart consumer electronics, semiconductors and other high-value components. ESI is headquartered in Portland, Oregon, with global operations from the Pacific Northwest to the Pacific Rim. For more information, visit the company’s website at visit: www.esi.com

Finjan Holdings, Inc. (FNJN)

Finjan Holdings, Inc. (OTCQB: FNJN) is a technology company committed to investing in and enabling technology innovation. The company has built a diverse portfolio of more than 40 patent assets around the world and has licensed its intellectual property to five major software and technology companies resulting in more than $145 million in licensing and enforcement revenues to date. Finjan continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment and strategic partnerships. For more information, visit the company’s website at www.finjan.com

FlexShopper, Inc. (FPAY)

FlexShopper, Inc. (OTCQB: FPAY) is a financial and technology company catering to U.S. consumers with limited cash or credit needed to acquire durable goods. The company’s proprietary “LTO Engine” technology platform automates the process of consumers receiving spending limits and entering into leases for durable goods within a few minutes. FlexShopper’s primary sales channels includes serving as the financial and technology partner for durable goods retailers and e-tailers, selling directly to consumers via the online FlexShopper LTO Marketplace, and utilizing the patent pending LTO payment method at check out. For more information, visit the company’s website at www.flexshopper.com

Full Circle Capital Corp. (FULL)

Full Circle Capital Corp. (NASDAQ: FULL) is a closed-end investment company that lends to and invests in senior secured loans and, to a lesser extent, mezzanine loans and equity securities issued by lower middle-market companies that operate in a diverse range of industries. Full Circle’s investment objective is to generate both current income and capital appreciation through debt and equity investments. The company’s investments generally range in size from $3 million to $10 million. For more information, visit the company’s website at www.fccapital.com

Fusion Telecommunications International, Inc. (FSNN)

Fusion Telecommunications International, Inc. (OTCQB: FSNN) provides integrated cloud solutions to small, medium and large businesses. Fusion’s advanced service platform enables the integration of leading-edge solutions in the cloud, including cloud voice, cloud connectivity, and cloud applications such as storage and security. The company’s cloud solutions lower customers’ cost of ownership, and deliver new levels of security, flexibility, scalability and speed of deployment. For more information, visit the company’s website at www.fusiontel.com

Gilat Satellite Networks Ltd. (GILT)

Gilat Satellite Networks Ltd. (NASDAQ: GILT) provides products and services for satellite-based broadband communications. The company develops and markets a wide range of high-performance satellite ground segment equipment and VSATs, with an increasing focus on the consumer and Ka-band market. Gilat also enables mobile SOTM (Satellite-on-the-Move) solutions providing low-profile antennas, next generation, solid-state power amplifiers and modems. Through its subsidiaries in Peru and Columbia, Gilat provides managed network and satellite-based services. For more information, visit the company’s website at www.gilat.com

Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics, Inc. (OTCBB: GTHP) utilizes its patented biophotonic technology for the development of a testing platform that uses light for the early detection of disease at the cellular level. The company’s first planned product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, LuVida® demonstrated its ability to detect cervical cancer up to two years earlier than conventional modalities. Guided Therapeutics is also using the technology to develop a non-invasive test for Barrett’s Esophagus. For more information, visit the company’s website at www.guidedinc.com

HealthWarehouse.com, Inc. (HEWA)

HealthWarehouse.com, Inc. (OTCQB: HEWA) is a virtual retail pharmacy and healthcare e-commerce company that sells a range of prescription drugs; diabetic supplies; and OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids. It also offers home medical supplies, such as incontinence supplies, first aid kits, and mobility aids; and diet and nutritional products comprising supplements, weight loss aids, and vitamins and minerals. HEWA also operates as a licensed mail-order pharmacy for sales to 50 states and the District of Columbia. For more information, visit the company’s website at www.healthwarehouse.com

Heat Biologics, Inc. (HTBX)

Heat Biologics, Inc. (NASDAQ: HTBX) is a clinical-stage biopharmaceutical company developing novel ImPACT therapeutic vaccines to treat a wide range of cancers. ImPACTTherapy is designed to deliver live, genetically modified, irradiated human cells reprogrammed to "pump out" cancer-associated antigens. The technology is to be used in conjunction with a potent immune adjuvant called "gp96" to educate and activate a cancer patient's immune system to recognize and kill cancerous cells. Heat expects to enter phase 2 trials with its HS-110 against non-small cell lung cancer and is conducting phase 1/2 clinical trials with its HS-410 against bladder cancer. For more information, visit the company’s website at www.heatbio.com

Highpower International, Inc. (HPJ)

Highpower International, Inc. (NASDAQ: HPJ) is a developer, manufacturer and marketer of nickel-metal hydride (Ni-MH) and lithium rechargeable batteries, and a battery management systems and battery recycling provider. The company’s batteries are used in a wide range of applications such as electric buses, bikes, mobile devices, energy storage systems, power tools, medical equipment, digital and electronic devices, and personal care products. Highpower has advanced manufacturing facilities located in Shenzhen, Huizhou, and Ganzhou of China, and distributes its products to worldwide markets mainly in the United States, Europe, China and Southeast Asia. For more information, visit the company’s website at www.highpowertech.com

Hipcricket, Inc. (HIPP)

Hipcricket, Inc. (OTCBB: HIPP) provides a unified mobile engagement platform designed to promote awareness, sales and loyalty. The company’s AD LIFE® platform has been used by internationally recognized brands and agencies to power more than 400,000 campaigns across SMS, 2D/QR codes, mobile websites, advertising networks, social media and branded apps. For more information, visit the company’s website at www.hipcricket.com

hopTo (HPTO)

hopTo (OTCQB: HPTO) is the developer of a unique mobile productivity workspace application that enables users to search, access, aggregate, create, edit and share content from a mobile device by leveraging their own “personal cloud.” hopTo version 2.2 includes a Mac OSX File Connector and provides access to Microsoft Office® files (Word® documents, Excel® spreadsheets and PowerPoint® presentations) within cloud storage services like Box, Dropbox, Google Drive, OneDrive, and now Egnyte. For more information, visit the company’s website at www.hopto.com

Implant Sciences Corp. (IMSC)

Implant Sciences Corp. (OTCQB: IMSC) is developing and manufacturing advanced detection capabilities designed to counter and eliminate the ever-evolving threats from explosives and drugs. The company's proprietary technologies have been used in commercial products, thousands of which have been sold across more than 50 countries worldwide. Implant Sciences is the third manufacturer, and the only American-owned company, to currently have an ETD system named as a Qualified Product by the U.S. Transportation Security Administration. For more information, visit the company’s website at www.implantsciences.com

IntelliCell BioSciences, Inc. (SVFC)

IntelliCell BioSciences, Inc. (OTC: SVFC) is a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. The company is also exploring technology-licensing agreements with technology developers, universities, and international business entities. For more information, visit the company’s website at www.intellicellbiosciences.com

Interactive Health (IGRW)

Interactive Health (OTC: IGRW) manufactures, markets and sells lifestyle products and nutraceuticals. The company’s wholly owned subsidiary, Cannabis Health Group, focuses on the medical marijuana and hemp market space. Interactive Health plans to extend its product lines through acquisitions to include other progressive market segments. Interactive Health Network will not cultivate, handle, transport, grow, extract, dispense, put up for sale, put on the market, vend, deliver, circulate, or trade cannabis products or any substances that violates the U.S. Law or Controlled Substance Act. For more information, visit the company’s website at www.interactivehealthnetwork.com

Interlink Electronics (LINK)

Interlink Electronics (OTCPK: LINK) specializes in human-machine interface (HMI) and sensor technologies, such as its patented Force-Sensing Resistor (FSR®) technology, applicable to consumer electronics, automotive, industrial, medical devices and more. The company’s solutions focus on handheld user input, menu navigation, cursor control and other intuitive interface technologies for electronics manufacturers. Interlink Electronics is headquartered in Camarillo, California, and has a printed-electronics factory in China, a global distribution and warehouse facility in Hong Kong, global R&D office in Singapore, a global sales office in the United Kingdom, and sales office in Japan. For more information, visit the company’s website at www.interlinkelectronics.com

International Commercial Television, Inc. (ICTL)

International Commercial Television, Inc. (OTCQB: ICTL) sells various health, wellness and beauty products through infomercials and other channels primarily in the United States. The company utilizes a distinctive marketing strategy and multi-channel distribution model to develop, market and sell products through infomercials, live home shopping television, specialty outlets and online shopping. It offers health and beauty products, including DermaWand, a skin care device, and DermaVitál, a professional quality skin care range that effects superior hydration. For more information, visit the company’s website at www.ictvonline.com

Iveda Solutions, Inc. (IVDA)

Iveda Solutions, Inc. (OTCQB: IVDA) is a premier cloud video hosting service provider focused on espousing cloud-based video surveillance services that ensure the security of businesses and communities to reduce capital expenditures. Customers can remotely access centrally managed live and archived video, without buying and maintaining software and equipment. The company has a SAFETY Act Designation from the Department of Homeland Security as a Qualified Anti-Terrorism Technology Provider. Iveda is headquartered in Mesa, Arizona, and has a subsidiary in Taiwan (MEGAsys). For more information, visit the company’s website at www.iveda.com

Keating Capital (KIPO)

Keating Capital (NASDAQ: KIPO) is a closed-end fund (regulated as a business development company under the Investment Company Act of 1940) that specializes in making pre-IPO investments in emerging growth companies that are committed to and capable of becoming public. Keating Capital provides investors with the ability to participate in a publicly traded fund that allows its stockholders to share in the potential value accretion that Keating Capital believes typically occurs once a company transforms from private to public status. For more information, visit the company’s website at www.keatingcapital.com

Lantronix, Inc. (LTRX)

Lantronix, Inc. (NASDAQ: LTRX) provides secure communication technologies that are designed to simplify access and communication with and between virtually any electronic device. The company’s smart connectivity solutions enable sharing data between devices and applications via networks and the Internet. Lantronix products have applications in every industry, including medical, security, industrial and building automation, transportation, retail, POS, financial, government, consumer electronics, and IT/data center. For more information, visit the company’s website at www.lantronix.com

Lightlake Therapeutics, Inc. (LLTP)

Lightlake Therapeutics, Inc. (OTCQB: LLTP) is a biopharmaceutical company that develops treatments for common addictions and related disorders. Lightlake currently is developing an intranasal naloxone treatment to reverse opioid overdoses. The company has collaborated with the Division of Pharmacotherapies and Medical Consequences of Drug Abuse of NIDA, part of the National Institute of Health, to develop this treatment. Lightlake also is focused on developing treatments in other areas, including for patients with Binge Eating Disorder, Bulimia Nervosa, and opioid drug addiction. For more information, visit the company’s website at www.lightlaketherapeutics.com

Liquid Holdings Group, Inc. (LIQD)

Liquid Holdings Group, Inc. (NASDAQ: LIQD) is a cloud-based technology and managed services provider to the global hedge fund and active trading markets, delivering its solutions efficiently and securely through the cloud in an SaaS model. The Liquid platform manages the entire trade lifecycle by integrating multi-currency, multi-asset trade order management, and execution with real-time risk, portfolio management, and shadow account reporting through a single solution. The Liquid platform and its components are available on a subscription basis to hedge fund managers, asset managers, family offices and financial institutions worldwide. For more information, visit the company’s website at www.liquidholdings.com

Local Corp. (LOCM)

Local Corp. (NASDAQ: LOCM) is a local advertising and technology company serving publishers, advertisers, retailers, and developers through a variety of innovative digital advertising products. Local connects businesses with online and mobile consumers through its consumer search business. The company’s growth strategy is to expand its network products with new display, pay-per-click, mobile search and pay-per-call ad formats, and by monetizing its patented local shopping and discovery platform Krillion®. This platform aggregates, normalizes and distributes dynamic, national and regional retail shopping content from ~120,000 store locations, representing nearly 3 million localized products. For more information, visit the company’s website at www.corporate.local.com

LRAD Corp. (PANG)

LRAD Corp. (NASDAQ: PANG) provides long-range communication solutions to peacefully resolve uncertain situations and potentially save lives on both sides of its proprietary Long Range Acoustic Device®, a hailing and warning, directed acoustic device designed to communicate with authority and high intelligibility. LRAD® systems are sold in 70 countries for a variety of diverse applications, including fixed and mobile military deployments, maritime security, critical infrastructure and perimeter security, commercial security, border and port security, law enforcement and emergency responder communications, emergency warning and mass notification, asset protection and wildlife preservation and control. For more information, visit the company’s website at www.lradx.com

Magnegas Corp. (MNGA)

Magnegas Corp. (NASDAQ: MNGA) is an energy and technology company with a portfolio of inventions, including a patented process that converts liquid waste into hydrogen-based fuels. The company sells MagneGas® to the metal working market as a replacement to acetylene. It also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, Magnegas is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information, visit the company’s website at www.magnegas.com

MamaMancini's Holdings, Inc.
(MMMB)

MamaMancini's Holdings, Inc. (OTCBB: MMMB) manufactures and distributes a line of authentic all natural, beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, pork meatballs with sauce, and other similar Italian products. The company's expanding distribution channel includes major retailers such as Costco, Publix, Shop Rite, Whole Foods, Kroger, Winn Dixie, Albertsons, Wal-Mart, K Mart Super Centers and more. MamaMancini's products are currently available in 8,100 stores nationwide. MamaMancini’s is introducing seven new items this spring and anticipates introducing 3-4 additional items this summer. For more information, visit the company’s website at www.mamamancinis.com

Mantra Venture Group, Ltd.
(MVTG)

Mantra Venture Group, Ltd. (OTCQB: MVTG) is a clean technology “incubator” focused on moving innovative emerging technologies toward commercialization. Through its subsidiary, Mantra Energy Alternatives, the company is currently developing two groundbreaking electrochemical technologies designed to make reducing greenhouse gas emissions profitable: Electro-Reduction of Carbon Dioxide (ERC) and Mixed-Reactant Fuel Cell (MRFC). Acquiring the intellectual property in 2008, Mantra Energy continues to develop ERC, which is now on the path toward mass commercial application. For more information, visit the company’s website at www.mantraventuregroup.com

Mantra Venture Group, Ltd.
(MVTG)

Mantra Venture Group, Ltd. (OTCQB: MVTG) is a clean technology “incubator” focused on moving innovative emerging technologies toward commercialization. Through its subsidiary, Mantra Energy Alternatives, the company is currently developing two groundbreaking electrochemical technologies designed to make reducing greenhouse gas emissions profitable: Electro-Reduction of Carbon Dioxide (ERC) and Mixed-Reactant Fuel Cell (MRFC). Acquiring the intellectual property in 2008, Mantra Energy continues to develop ERC, which is now on the path toward mass commercial application. For more information, visit the company’s website at www.mantraventuregroup.com

Medbox, Inc. (MDBX)

Medbox, Inc. (OTCQB: MDBX), through its wholly owned subsidiary Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments. Through another wholly owned subsidiary, Vaporfection International, Inc., Medbox offers a medical vaporizer product. Additionally, through its newly established subsidiaries, Medbox is developing a range of ancillary services for the alternative medicine industry, including merchant services and armored transport for cash deposits, cannabidiol R&D, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services. For more information, visit the company’s website at www.medbox.com

Medient Studios, Inc. (MDNT)

Medient Studios, Inc. (OTCQB: MDNT) is an entertainment content creation company with a presence in North America, Europe and India. The company’s management team has approximately 150 years of experience in the motion picture industry and is responsible for producing and/or financing more than 250 movies. Medient is building a fully integrated movie and electronic game production facility as part of its Studioplex on a 1,550-acre property in Effingham County, Georgia. Once operational this production facility will be the largest of its kind in the United States. For more information, visit the company’s website at www.medient.com

MediFocus, Inc. (MDFZF)

MediFocus, Inc. (OTCQX: MDFZF) owns two fully developed technology platforms that the company believes can provide the design basis for the development of multiple cancer treatment systems. These technologies have comprehensive U.S. and international patent protection: The Endo-thermotherapy Platform, which is the base for the company’s FDA-approved Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia (BPH); and the Adaptive Phased Array (APA) Microwave Focusing Platform, which is the base for Medifocus' APA 1000 Breast Cancer Treatment System. For more information, visit the company’s website at: www.medifocusinc.com

Milestone Scientific, Inc. (MLSS)

Milestone Scientific, Inc. (OTCQB: MLSS), a medical research and development company that designs innovative injection technology, has developed computer-controlled systems designed to make injections precise, efficient and virtually painless. The company’s patented CompuFlo® system and DPS Dynamic Pressure Sensing® technologies are relevant for the entire category of subcutaneous drug delivery injections and fluid aspiration. The technology empowers clinicians to receive real-time continuous feedback pertaining to the local tissue conditions during the injection process. For more information, visit the company’s website at www.milestonescientific.com

MVC Capital, Inc. (MVC)

MVC Capital, Inc. (NYSE: MVC) provides long-term equity and debt investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the United States. MVC's investments can take the form of common and preferred stock (control and non-control investments) and warrants or rights to acquire equity interests; senior and subordinated loans; or convertible securities. MVC serves as the lead investor for transactions, as well as a co-investor in companies along with other private equity sponsors. For more information, visit the company’s website at www.mvccapital.com

MYOS Corp. (MYOS)

MYOS Corp. (OTCQB: MYOS) is a development stage company engaged in the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia (age-related loss of muscle mass), cachexia (general physical wasting and malnutrition), and degenerative muscle diseases. The company’s Fortetropin™ (also known as MYO-T12®) is the first clinically proven natural myostatin inhibitor. Myostatin is a natural regulatory protein that inhibits muscle growth and recovery; research suggests that lowering myostatin levels has many health benefits, including increased muscle mass, healthy weight management, improved energy levels, and stimulated muscle healing. For more information, visit the company’s website at www.myoscorp.com

 
Twitter

For more frequent updates, follow us on Twitter!

Home     About Us     Blog     Investors     IR Services     Market Research     Partners     Contact     Disclaimer

© 2013 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975